Document is current
Any future updates will be listed below
-
Authors
Wright, Ian
Jongejan, Frans
Marcondes, Mary
Peregrine, Andrew
Baneth, Gad
Bourdeau, Patrick
Bowman, Dwight D.
Breitschwerdt, Edward B.
Capelli, Gioia
Cardoso, Luís
Dantas-Torres, Filipe
Day, Michael J.
Dobler, Gerhard
Ferrer, Lluis
Gradoni, Luigi
Irwin, Peter
Kempf, Volkhard A. J.
Kohn, Barbara
Krämer, Friederike
Lappin, Michael
Madder, Maxime
Maggi, Ricardo G.
Maia, Carla
Miró, Guadalupe
Naucke, Torsten
Oliva, Gaetano
Otranto, Domenico
Pennisi, Maria Grazia
Penzhorn, Barend L.
Pfeffer, Martin
Roura, Xavier
Sainz, Angel
Shin, SungShik
Solano-Gallego, Laia
Straubinger, Reinhard K.
Tasker, Séverine
Traub, Rebecca
Little, Susan
-
Funding
Funding for this research was provided by:
Bayer Animal Health (TC00685704)
- License Information
-
More Information
Article History
Received: 30 September 2020
Accepted: 21 October 2020
First Online: 10 November 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests. The authors are members of the CVBD World Forum. The CVBD World Forum was founded during the 1st International CVBD Symposium from April 18th to 20th, 2006, in Billesley, UK, as a consequence of the increasing global threats through vector-borne diseases. The CVBD World Forum is supported by Bayer Animal Health, which is now part of Elanco.
